Form D · Other Technology

Iagnosis, Inc.

Pittsburgh, PA · CIK 0001543039

Offering snapshot reported Jun 15, 2017 · SEC filing

Reported sold
$2.07M
Offering amount: $3.7M
Investors reported
19
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 31, 2017
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 15, 2017Initial$2,069,159No comparison19SEC filing
Jul 15, 2016Initial$931,110No comparison14SEC filing
Feb 23, 2015Initial$1,251,604No comparison12SEC filing
Dec 30, 2013Initial$5,925,658No comparison40SEC filing
Dec 30, 2013Amendment$5,925,658$0vs Dec 30, 201340SEC filing
Mar 5, 2013Amendment$4,000,000$3,000,000vs Feb 23, 201236SEC filing
Feb 23, 2012Initial$1,000,000No comparison11SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-288839

Source: Form D, filed Jun 15, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Lawrence E. Eakin Director, Executive
Lawrence E. Eakin, Jr. Director
Michael Rossi Director
Mark P. Seraly Director, Executive
Peter N. Stephans Director
David A. Zynn Director, Executive

Issuer details

Industry: Other Technology (See others in industry)

Address:
4 Smithfield Street 11 Th Floor
Pittsburgh, PA, 15222